Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.42M | 5.25M | 5.11M | 5.18M | 5.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.42M | 5.25M | 5.11M | 5.18M | 5.36M |
| Cost of Revenue | 1.77M | 1.51M | 1.26M | 1.34M | 1.46M |
| Gross Profit | 3.65M | 3.73M | 3.85M | 3.84M | 3.90M |
| SG&A Expenses | 9.83M | 9.56M | 9.36M | 9.19M | 9.23M |
| Depreciation & Amortization | 8.25M | 8.61M | 9.02M | 9.07M | 9.30M |
| Other Operating Expenses | 7.02M | 6.77M | 6.56M | 5.84M | 5.26M |
| Total Operating Expenses | 26.87M | 26.45M | 26.20M | 25.44M | 25.25M |
| Operating Income | -21.45M | -21.21M | -21.09M | -20.26M | -19.90M |
| Income Before Tax | -21.45M | -20.69M | -20.04M | -19.02M | -18.47M |
| Income Tax Expenses | 49.00K | 53.40K | 57.90K | 62.90K | 70.20K |
| Earnings from Continuing Operations | -21.50 | -20.74 | -20.10 | -19.09 | -18.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.50M | -20.74M | -20.10M | -19.09M | -18.54M |
| EBIT | -21.45M | -21.21M | -21.09M | -20.26M | -19.90M |
| EBITDA | -16.35M | -15.05M | -13.81M | -13.99M | -14.55M |
| EPS Basic | -0.36 | -0.34 | -0.33 | -0.32 | -0.31 |
| Normalized Basic EPS | -0.22 | -0.21 | -0.21 | -0.20 | -0.19 |
| EPS Diluted | -0.36 | -0.34 | -0.33 | -0.32 | -0.31 |
| Normalized Diluted EPS | -0.22 | -0.21 | -0.21 | -0.20 | -0.19 |
| Average Basic Shares Outstanding | 241.42M | 241.40M | 241.38M | 241.38M | 241.37M |
| Average Diluted Shares Outstanding | 241.42M | 241.40M | 241.38M | 241.38M | 241.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |